Begin a Conversation

We invest in foundational institutional infrastructure technology across nine core domains: regulatory technology, cybersecurity, decision intelligence, computational biology, climate technology, medical technology, resilient logistics engineering, enterprise automation, and geopolitical risk platforms. We seek companies whose products function as structural necessities rather than discretionary tools.

Our investments are structured as long-duration capital partnerships with seven to ten year horizons. We deploy patient capital with a focus on structural value creation rather than financial engineering. Specific terms are discussed during the review process and tailored to each opportunity.

First review of submitted opportunities usually concludes within two weeks. Companies that advance to the formal due diligence stage undergo a thorough assessment using our MPPT-CoT review-based framework, which usually spans four to eight weeks depending on complexity.

Our main focus is North American institutional technology companies, though we evaluate opportunities globally where the technology addresses foundational infrastructure needs. International investments are assessed with more consideration for regulatory environment, market structure, and operational integration requirements.

You may subscribe to Architect Insights, our quarterly publication covering market perspectives and expertise, by selecting the subscription option when submitting an inquiry through this form. We also publish review-based content on our Insights page.